CATALYST BIOSCIENCES INC (CBIO)

US14888D2080 - Common Stock

0.5113  -0.01 (-2.65%)

After market: 0.5406 +0.03 (+5.73%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.00794.00K7.34M20.95M0.00
Cost Of Goods
0.00798.00K7.38M9.16MN/A
Gross Profit
0.00-4.00K-42.00K11.79MN/A
Operating Expenses
13.55M29.40M87.85M68.36M57.28M
Research and Development
1.98M12.44M68.89M52.18M43.86M
Selling, General, and Administrative Expenses
12.77M16.97M18.96M16.18M13.42M
Operating Income
-13.55M-29.41M-87.89M-56.57M-57.28M
Interest Income/Expense
383.00K537.00K39.00K560.00K2.15M
Other Income/Expense
N/A0.00-78.00K570.00K-50.00K
Non Recurring Items
-30.71M20.98MN/A-800.00KN/A
Income Before Taxes
-43.88M-7.89M-87.93M-56.24M-55.18M
Income Tax
364.00K348.00KN/AN/AN/A
Net Income
-44.24M-8.24M-87.93M-56.24M-55.18M
EBITDA
N/A-29.18M-87.60M-56.47M-57.18M
 
Per Share Data
EPS Diluted Total Ops
-1.37-0.26-2.87-2.93-4.60
Non GAAP EPS
N/AN/A-2.87-2.83-4.60
 
Statistics
Gross Profit Margin
N/A-0.50%-0.57%56.28%N/A
Profit Margin
N/A-1038.04%-1198.32%-268.45%N/A
Operating Profit Margin
N/A-3703.65%-1197.79%-270.02%N/A

All data in USD

Charts